RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2006; 95(05): 912-913
DOI: 10.1160/TH06-01-0009
DOI: 10.1160/TH06-01-0009
Letters to the Editor
Recurrent venous thromboembolism under anticoagulant therapy: A high risk in adenocarcinoma?
Authors
Financial support: This work is partially funded by the French Ministry of Health (“Projets Hospitaliers de recherche Clinique”).
Weitere Informationen
Publikationsverlauf
Received
10. Januar 2006
Accepted after resubmission
09. März 2006
Publikationsdatum:
01. Dezember 2017 (online)
-
References
- 1 Heit JA, O’Fallon WM, Petterson TM. et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-8.
- 2 Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107 Suppl: (Suppl. 01) I17-I21.
- 3 Blom JW, Doggen CJ, Osanto S. et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
- 4 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 Suppl: (Suppl. 03) 338S-400S.
- 5 Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2004; 02: 1760-5.
- 6 Lee A, Levine M. Treatment of venous thromboembolism in cancer patients. Cancer Control 2005; 12 Suppl: (Suppl. 01) 17-21.
- 7 Lee AY, Levine MN, Baker RI. et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
- 8 Lacut K, Oger E, Le Gal G. et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol 2004; 18: 477-82.
- 9 Linkins LA, Stretton R, Probyn L. et al. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res 2006; 117: 241-7.
- 10 Trousseau A. Phlegmatia alba dolens. Clinique médicale de l’Hôtel Dieu. Paris: 1861
- 11 Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002; 87: 575-9.
- 12 Wahrenbrock M, Borsig L, Le D. et al. Selectinmucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 2003; 112: 853-62.